In total, the CD19-positive cells comprised between 10.3 and 80.3% of the entire myeloma cell population (mean: 54 ± 7%; of all 10 CD19-positive myeloma patients) (Fig. 2e and Table 1). Here, CD19 is linked to plasma cell myeloma.